Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
A sortable and searchable running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.
The post-COVID-19 medtech industry continues to be a difficult space for both investors and entrepreneurs, but support for innovation is still available for companies that can navigate the challenges of early commercialization and reimbursement, according to the presenters at the Transcatheter Cardiovascular Therapeutics conference in Washington, DC.
Venture funding for US digital health companies started off strong in 2024, but this potential rising tide may not lift all boats. Excerpted from our recent feature article.